Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

RVP vs MMSI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RVP
Retractable Technologies, Inc.

Medical - Instruments & Supplies

HealthcareAMEX • US
Market Cap$21M
5Y Perf.-87.2%
MMSI
Merit Medical Systems, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$3.65B
5Y Perf.+36.2%

RVP vs MMSI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RVP logoRVP
MMSI logoMMSI
IndustryMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$21M$3.65B
Revenue (TTM)$38M$1.54B
Net Income (TTM)$-9M$139M
Gross Margin-6.9%48.7%
Operating Margin-58.1%12.2%
Forward P/E15.1x
Total Debt$1M$898M
Cash & Equiv.$4M$449M

RVP vs MMSILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RVP
MMSI
StockMay 20May 26Return
Retractable Technol… (RVP)10012.8-87.2%
Merit Medical Syste… (MMSI)100136.2+36.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: RVP vs MMSI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MMSI leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Retractable Technologies, Inc. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
RVP
Retractable Technologies, Inc.
The Defensive Pick

RVP is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.72, Low D/E 1.4%, current ratio 8.34x
  • 1.1% yield; the other pay no meaningful dividend
  • -7.4% vs MMSI's -36.2%
Best for: sleep-well-at-night
MMSI
Merit Medical Systems, Inc.
The Income Pick

MMSI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.66
  • Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
  • 209.3% 10Y total return vs RVP's -70.2%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMMSI logoMMSI11.7% revenue growth vs RVP's -24.2%
Quality / MarginsMMSI logoMMSI9.0% margin vs RVP's -22.9%
Stability / SafetyMMSI logoMMSIBeta 0.66 vs RVP's 0.72
DividendsRVP logoRVP1.1% yield; the other pay no meaningful dividend
Momentum (1Y)RVP logoRVP-7.4% vs MMSI's -36.2%
Efficiency (ROA)MMSI logoMMSI5.2% ROA vs RVP's -5.9%, ROIC 7.2% vs -18.4%

RVP vs MMSI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RVPRetractable Technologies, Inc.
FY 2024
License
80.5%$189,000
Other Products
19.5%$45,852
MMSIMerit Medical Systems, Inc.
FY 2025
Cardiovascular
95.2%$1.4B
Endoscopy
4.8%$73M

RVP vs MMSI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMMSILAGGINGRVP

Income & Cash Flow (Last 12 Months)

MMSI leads this category, winning 4 of 6 comparable metrics.

MMSI is the larger business by revenue, generating $1.5B annually — 40.4x RVP's $38M. MMSI is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to RVP's -22.9%. On growth, RVP holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
RevenueTrailing 12 months$38M$1.5B
EBITDAEarnings before interest/tax-$15M$290M
Net IncomeAfter-tax profit-$9M$139M
Free Cash FlowCash after capex-$14M$274M
Gross MarginGross profit ÷ Revenue-6.9%+48.7%
Operating MarginEBIT ÷ Revenue-58.1%+12.2%
Net MarginNet income ÷ Revenue-22.9%+9.0%
FCF MarginFCF ÷ Revenue-35.5%+17.8%
Rev. Growth (YoY)Latest quarter vs prior year+73.2%+7.8%
EPS Growth (YoY)Latest quarter vs prior year+99.0%+38.8%
MMSI leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

RVP leads this category, winning 3 of 3 comparable metrics.
MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
Market CapShares × price$21M$3.7B
Enterprise ValueMkt cap + debt − cash$18M$4.1B
Trailing P/EPrice ÷ TTM EPS-1.74x28.77x
Forward P/EPrice ÷ next-FY EPS est.15.05x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.87x
Price / SalesMarket cap ÷ Revenue0.63x2.41x
Price / BookPrice ÷ Book value/share0.24x2.34x
Price / FCFMarket cap ÷ FCF16.95x
RVP leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

MMSI leads this category, winning 6 of 9 comparable metrics.

MMSI delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-11 for RVP. RVP carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMSI's 0.57x. On the Piotroski fundamental quality scale (0–9), MMSI scores 6/9 vs RVP's 4/9, reflecting solid financial health.

MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
ROE (TTM)Return on equity-11.4%+8.9%
ROA (TTM)Return on assets-5.9%+5.2%
ROICReturn on invested capital-18.4%+7.2%
ROCEReturn on capital employed-13.1%+7.9%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.01x0.57x
Net DebtTotal debt minus cash-$3M$450M
Cash & Equiv.Liquid assets$4M$449M
Total DebtShort + long-term debt$1M$898M
Interest CoverageEBIT ÷ Interest expense-81.41x10.74x
MMSI leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MMSI leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in MMSI five years ago would be worth $9,727 today (with dividends reinvested), compared to $742 for RVP. Over the past 12 months, RVP leads with a -7.4% total return vs MMSI's -36.2%. The 3-year compound annual growth rate (CAGR) favors MMSI at -10.3% vs RVP's -23.9% — a key indicator of consistent wealth creation.

MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
YTD ReturnYear-to-date-8.3%-29.1%
1-Year ReturnPast 12 months-7.4%-36.2%
3-Year ReturnCumulative with dividends-55.9%-27.8%
5-Year ReturnCumulative with dividends-92.6%-2.7%
10-Year ReturnCumulative with dividends-70.2%+209.3%
CAGR (3Y)Annualised 3-year return-23.9%-10.3%
MMSI leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

MMSI leads this category, winning 2 of 2 comparable metrics.

MMSI is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than RVP's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
Beta (5Y)Sensitivity to S&P 5000.72x0.66x
52-Week HighHighest price in past year$1.14$100.19
52-Week LowLowest price in past year$0.60$59.74
% of 52W HighCurrent price vs 52-week peak+61.1%+61.2%
RSI (14)Momentum oscillator 0–10057.437.3
Avg Volume (50D)Average daily shares traded57K758K
MMSI leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

RVP is the only dividend payer here at 1.10% yield — a key consideration for income-focused portfolios.

MetricRVP logoRVPRetractable Techn…MMSI logoMMSIMerit Medical Sys…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$95.00
# AnalystsCovering analysts14
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.01
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

MMSI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RVP leads in 1 (Valuation Metrics).

Best OverallMerit Medical Systems, Inc. (MMSI)Leads 4 of 6 categories
Loading custom metrics...

RVP vs MMSI: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is RVP or MMSI a better buy right now?

For growth investors, Merit Medical Systems, Inc.

(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -24. 2% for Retractable Technologies, Inc. (RVP). Merit Medical Systems, Inc. (MMSI) offers the better valuation at 28. 8x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — RVP or MMSI?

Over the past 5 years, Merit Medical Systems, Inc.

(MMSI) delivered a total return of -2. 7%, compared to -92. 6% for Retractable Technologies, Inc. (RVP). Over 10 years, the gap is even starker: MMSI returned +209. 3% versus RVP's -70. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — RVP or MMSI?

By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.

(MMSI) is the lower-risk stock at 0. 66β versus Retractable Technologies, Inc. 's 0. 72β — meaning RVP is approximately 8% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Retractable Technologies, Inc. (RVP) carries a lower debt/equity ratio of 1% versus 57% for Merit Medical Systems, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — RVP or MMSI?

By revenue growth (latest reported year), Merit Medical Systems, Inc.

(MMSI) is pulling ahead at 11. 7% versus -24. 2% for Retractable Technologies, Inc. (RVP). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -66. 7% for Retractable Technologies, Inc.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — RVP or MMSI?

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus -36. 0% for Retractable Technologies, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus -63. 9% for RVP. At the gross margin level — before operating expenses — MMSI leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — RVP or MMSI?

In this comparison, RVP (1.

1% yield) pays a dividend. MMSI does not pay a meaningful dividend and should not be held primarily for income.

07

Is RVP or MMSI better for a retirement portfolio?

For long-horizon retirement investors, Retractable Technologies, Inc.

(RVP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), 1. 1% yield). Both have compounded well over 10 years (RVP: -70. 2%, MMSI: +209. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between RVP and MMSI?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

RVP pays a dividend while MMSI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

RVP

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 36%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

MMSI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RVP and MMSI on the metrics below

Revenue Growth>
%
(RVP: 73.2% · MMSI: 7.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.